INS and cancer: For example, dysregulation of insulin-IGF-1 axis, sex hormones, or adipokines in obese individuals might result in multiple systemic metabolic alterations, such as insulin resistance, hyperglycemia, and chronic inflammation that can contribute to increased cancer risk in such patients [23,24].